Home
Click

Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Sura Aziz defended Tuesday June 27th 2017 her dissertation: “Biological and clinico-pathologic markers in breast cancer, with focus on histologic features, markers of proliferation and angiogenesis” at the University of Bergen.
Anna Berg defended June 22nd 2017 her dissertation: «Molecular alterations and diagnostic imaging in premalignant and malignant endometrial lesions for improved diagnosis and treatment» at the University of Bergen.
Inga Reigstad defended Thursday June 22nd 2017 her dissertation "Investigation of different aspects of the tumor microenvironment as determinants of tumor development and progression".
The p53 community met at Haukeland Campus for the 3rd international p53 isoform conference, 18th to 21st of June. CCBIO had the great pleasure of hosting The Third International p53 Isoform conference at Basic Biology-building, UIB Haukeland Campus. We welcomed researchers from all corners of the world including the pioneers who contributed in discovery and crucial first investigations in the... Read more
The Centre for Cancer Biomarkers CCBIO, in collaboration with Helse Vest, arranged on June 18.-19. 2017 a new type of symposium focusing on the methodology required to identify new biomarkers in patient materials.
The ethics, economics and ELSA research groups of CCBIO are coordinating their research activities ever more. In April they published their first joint book volume "Cancer Biomarkers: Ethics, Economics and Society".
Congratulations to Emilia Hugdahl for the YDF-award from the Norwegian Society of Dermatology and Venereology!
The Centre for Cancer Biomarkers CCBIO met for the 5th time at their Annual Symposium at Solstrand 19-20 April. "We wish to motivate, especially the younger researchers, to perform excellent cancer research," says Center Director Lars A. Akslen.
«Seek international experiences !» recommends CCBIO Director Lars A. Akslen to the students of today.
Centre for Cancer Biomarkers møttes for femte gang på sitt årlige symposium på Solstrand 19-20 april. – Vi ønsker å motivere, særlig yngre forskere, til fremragende kreftforskning, sier senterleder Lars A. Akslen.
Now you can read the brand new CCBIO Annual Report 2016!
The regional health authorities' joint program for clinical therapy research (KLINBEFORSK) has February 27th 2017 allocated in total 124 million NOK to seven large research projects. The projects are closely linked to patient care and the requirements of the specialist health services. One of the supported projects is led by CCBIO PI Oddbjørn Straume, receiving 17,57 million NOK over five... Read more
Responsible cancer research should combine biomedical research activities with critical analysis of the same research, says CCBIO's Roger Strand and Lars A. Akslen in a recently published "perspectives" piece in the Norwegian medical journal "Tidsskriftet for Den norske legeforening".
Thursday, March 2nd 2017, this year's Thon funding was presented to the awardees at the University Aula in Oslo. CCBIO's Lars A. Akslen and Elisabeth Wik attended the prestigious ceremony to receive a grant in the category of national research-based teaching.
Maria Omsland defended Friday 03.02.2017 her dissertation «Investigation of the intercellular structure tunneling nanotube (TNT) in leukemia» at the University of Bergen.
Jan Roger Olsen defended January 27th 2017 his thesis ”Context dependent transcription factor regulation in normal and malignant cell differentiation” at the University of Bergen.
The Thon Foundation announced Thursday January 12th their allocations of funds for research. This year our faculty got two good reasons to celebrate. Professor Anne Berit Guttormsen at the Department of Clinical Medicine (K1) received an award for excellence in teaching, and CCBIO's Professor Lars A. Akslen and Postdoc Elisabeth Wik received support for the project "Harvard Cancer... Read more
The Norwegian Prime Minister Erna Solberg highlighted CCBIO PI James Lorens and his company BerGenBio in her New Year's Address as an example of excellent cancer research.

Pages